Sepriano, Alexandre
Ramiro, Sofia
Landewé, Robert
van der Heijde, Désirée
Ohrndorf, Sarah
FitzGerald, Olivier
Backhaus, Marina
Larché, Maggie
Homik, Joanne
Saraux, Alain
Hammer, Hilde B.
Terslev, Lene
Østergaard, Mikkel
Burmester, Gerd
Combe, Bernard
Dougados, Maxime
Hitchon, Carol
Boire, Gilles
Lambert, Robert G.
Dadashova, Rana
Paschke, Joel
Hutchings, Edna J.
Maksymowych, Walter P. http://orcid.org/0000-0002-1291-1755
Funding for this research was provided by:
AbbVie Canada
Article History
Received: 14 February 2024
Revised: 11 April 2024
Accepted: 22 April 2024
First Online: 29 April 2024
Declarations
:
: Alexandre Sepriano: speaking and/or consulting fees from Novartis, Abbvie, UCB and Lilly.Sofia Ramiro: research grants and/or consultancy fees: AbbVie, Eli Lilly, MSD, Novartis, SanofiRobert Landewé: Received consulting fees from AbbVie, BMS, Celgene, Eli-Lilly, Galapagos, Gilead, Glaxo-Smith-Kline, Janssen, Merck, Novartis, Pfizer, Roche, UCB and is Director of Rheumatology Consultancy bvDésirée van der Heijde: Received consulting fees from AbbVie, Amgen, Astellas, AstraZeneca, BMS, Boehringer Ingelheim, Celgene, Daiichi, Eli-Lilly, Galapagos, Gilead, Glaxo-Smith-Kline, Janssen, Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi, Takeda, UCB Pharma and is Director of Imaging Rheumatology bv.Sarah Ohrndorf: Received consulting fees from AbbVie, BMS, Novartis, and RocheOlivier FitzGerald: Has received research grants and/or consultancy fees: AbbVie, Eli Lilly, Celgene, Novartis, UCB, Pfizer, Amgen, JanssenMarina Backhaus: Has received research grant and/or consultancy fees: Abbvie, BMS, Celgene, Lilly, MSD, Novartis, Pfizer, Roche, UCBMaggie Larche: Received advisory board honoraria from AbbVie, Actelion, Boehringer Ingelheim, BMS, Janssen, Novartis, Pfizer, Sanofi, Roche; and an unrestricted educational grant from AbbVieJoanne Homik: NoneAlain Saraux: Research grants and/or consultancy fees by: AbbVie, BMS, Chugai, Eli Lilly, MSD, Nordic pharma, Novartis, Pfizer, Sanofi, UCBHilde B. Hammer: Has received fees for speaking and/or consulting from AbbVie, BMS, Pfizer, UCB, Roche, MSD and Novartis.Lene Terslev: Received speakers fee from Janssen, Roche, Novartis, UCB, MSD, BMS and GEMikkel Østergaard: Has received research support, consultancy fees and/or speaker fees from Abbvie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Hospira, Janssen, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, Sandoz, Sanofi and UCBGerd Burmester: Honoraria as speaker and for consulting: Abbvie, BMS, Gilead, Lilly, MSD, Pfizer, UCB, Roche, SanofiBernard Combe: Received consulting fees from AbbVie, BMS, Celltrion, Eli-Lilly, Galapagos, Gilead, Janssen, Merck, Novartis, Pfizer, Roche-Chugai.Maxime Dougados: Has received research grants from and honorarium fees for his participation at advisory boards and/or symposium organized by PFIZER, UCB, ABBVIE, LILLY, NOVARTIS, BMS, ROCHE, UCB, MERCK.Carol Hitchon: Has received unrelated research grants from Pfizer, UCBGilles Boire: Received consulting fees from Eli Lilly, Janssen, Novartis, Pfizer, Samsung Bioepis, Viatris, and speaker fees from BMS, Merck, Pfizer. Industry support for investigator-initiated research initiatives from Abbvie, BMS, Eli Lilly, Janssen, Merck, Pfizer, RocheRobert G. Lambert: Received consulting fees from Calyx, Care Arthritis and Image Analysis Group.Rana Dadashova: Senior Project Manager for CARE ARTHRITIS LTDJoel Paschke: noneEdna J. Hutchings: noneW.P. Maksymowych: Received consulting fees from AbbVie, Boehringer Ingelheim, Celgene, Eli-Lilly, Galapagos, Janssen, Novartis, Pfizer, UCB Pharma and is Chief Medical Officer of CARE ARTHRITIS LTD